ASP Isotopes (NASDAQ:ASPI) Trading Up 8.9% – Time to Buy?

ASP Isotopes Inc. (NASDAQ:ASPI) shares were up 8.9% on Friday . The stock traded as high as $6.84 and last traded at $6.7830. Approximately 1,514,542 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 5,216,768 shares. The stock had previously closed at $6.23.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ASPI shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Trading Up 3.2%

The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The firm’s 50-day moving average price is $5.69 and its 200 day moving average price is $5.85. The company has a market capitalization of $809.43 million, a P/E ratio of -3.10 and a beta of 3.42.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.06. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%. The company had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million.

Insider Activity

In other ASP Isotopes news, COO Robert Ainscow sold 8,438 shares of the business’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $7.00, for a total value of $59,066.00. Following the transaction, the chief operating officer directly owned 2,281,879 shares in the company, valued at $15,973,153. The trade was a 0.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52. Following the completion of the transaction, the chief financial officer owned 709,376 shares in the company, valued at approximately $3,887,380.48. The trade was a 3.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 233,221 shares of company stock valued at $1,707,989. 14.40% of the stock is currently owned by company insiders.

Institutional Trading of ASP Isotopes

Institutional investors have recently modified their holdings of the business. Rovida Investment Management Ltd lifted its stake in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after buying an additional 1,000,000 shares in the last quarter. Caprock Group LLC purchased a new stake in ASP Isotopes in the 3rd quarter worth approximately $2,747,000. SPX Gestao de Recursos Ltda purchased a new stake in ASP Isotopes in the 3rd quarter worth approximately $1,054,000. Rathbones Group PLC lifted its stake in ASP Isotopes by 68.6% in the 4th quarter. Rathbones Group PLC now owns 399,599 shares of the company’s stock worth $2,138,000 after purchasing an additional 162,535 shares in the last quarter. Finally, Tudor Investment Corp ET AL lifted its stake in ASP Isotopes by 37.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 460,685 shares of the company’s stock worth $4,432,000 after purchasing an additional 125,687 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.